Open AccessFriend or foe—The Pfizer‐BioNTech ( BNT162b2 ) vaccination: A case report of reversible acute acalculous cholecystitis
Author(s) -
Wahlen Bianca Maria,
Peralta Ruben,
AlThani Hassan,
ElMenyar Ayman
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6078
Subject(s) - medicine
We described a rare case of vaccine‐induced acalculous cholecystitis (ACC). A 52‐year‐old female developed ACC after 8 h of receiving a 3rd dose of the Pfizer‐BioNTech COVID‐19 vaccination. The symptoms subsided completely with conservative treatment for 12 days, and the ultrasound and laboratory findings went back to normal.